Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Oxford BioMedica plc
DescriptionLentiviral vector-based therapy
Molecular Target Not applicable
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Lentivirus
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today